US Oncology Marketing Launch Lead, Mevrometostat
Pfizer
About this role
This role leads the US launch of Pfizer’s late-stage prostate cancer therapy Mevrometostat, guiding market introduction and launch readiness for a major oncology franchise. The position heads the Mevrometostat US launch asset team and partners closely with Global Marketing and US cross-functional stakeholders to bring the product to market. It is based at select Pfizer US sites and includes travel for congresses, meetings, and customer interactions.
Skills
Qualifications
About Pfizer
pfizer.comBreakthroughs that change patients’ lives.
Recent company news
MarketBeatMackenzie Financial Corp Raises Holdings in Pfizer Inc. $PFE
4 hours ago
Yahoo FinancePfizer's Payout Ratio Is Still Over 100%. Is a Dividend Cut Inevitable?
2 days ago
Insider MonkeyPfizer’s Weight Management Drug Wins China Approval
10 hours ago
BritannicaPfizer Inc. | Pharmaceuticals, Vaccines & Company History | Britannica Money
2 weeks ago
Seeking AlphaPfizer Stock: Cheap For A Reason (NYSE:PFE)
1 day ago
About Pfizer
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Pfizer.
Salary
$177k – $283k
per year
More jobs at Pfizer
Similar Jobs
Executive Director, US Launch Lead – Prostate (STEAP-1 bi-specific)
Amgen
Senior Director, Global Regulatory Lead – Oncology
Takeda Pharmaceutical Company
Associate Director, US Market Insights – Gynecological Oncology
Genmab
Launch Lead (Oncology)
GSK plc
Associate Director, US Market Insights Solid Tumor/Oncology
Genmab
Oncology Franchise Head, Lung Cancer (Alliance), International
AstraZeneca